1. Home
  2. EMN vs MEDP Comparison

EMN vs MEDP Comparison

Compare EMN & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMN
  • MEDP
  • Stock Information
  • Founded
  • EMN 1920
  • MEDP 1992
  • Country
  • EMN United States
  • MEDP United States
  • Employees
  • EMN N/A
  • MEDP N/A
  • Industry
  • EMN Major Chemicals
  • MEDP Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • EMN Industrials
  • MEDP Health Care
  • Exchange
  • EMN Nasdaq
  • MEDP Nasdaq
  • Market Cap
  • EMN 12.0B
  • MEDP 10.5B
  • IPO Year
  • EMN 1993
  • MEDP 2016
  • Fundamental
  • Price
  • EMN $98.70
  • MEDP $340.22
  • Analyst Decision
  • EMN Buy
  • MEDP Buy
  • Analyst Count
  • EMN 13
  • MEDP 10
  • Target Price
  • EMN $113.77
  • MEDP $389.89
  • AVG Volume (30 Days)
  • EMN 1.2M
  • MEDP 317.8K
  • Earning Date
  • EMN 01-30-2025
  • MEDP 02-10-2025
  • Dividend Yield
  • EMN 3.36%
  • MEDP N/A
  • EPS Growth
  • EMN 2.40
  • MEDP 42.23
  • EPS
  • EMN 7.67
  • MEDP 12.63
  • Revenue
  • EMN $9,382,000,000.00
  • MEDP $2,109,054,000.00
  • Revenue This Year
  • EMN $3.27
  • MEDP $7.54
  • Revenue Next Year
  • EMN $4.14
  • MEDP $11.55
  • P/E Ratio
  • EMN $12.87
  • MEDP $26.94
  • Revenue Growth
  • EMN 1.87
  • MEDP 11.84
  • 52 Week Low
  • EMN $85.28
  • MEDP $302.01
  • 52 Week High
  • EMN $114.50
  • MEDP $459.77
  • Technical
  • Relative Strength Index (RSI)
  • EMN 51.53
  • MEDP 47.17
  • Support Level
  • EMN $98.63
  • MEDP $336.78
  • Resistance Level
  • EMN $103.82
  • MEDP $347.58
  • Average True Range (ATR)
  • EMN 2.20
  • MEDP 12.05
  • MACD
  • EMN -0.10
  • MEDP -0.79
  • Stochastic Oscillator
  • EMN 29.67
  • MEDP 34.48

About EMN Eastman Chemical Company

Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: